Description

Post-issue shareholding pattern filed under Regulation 31(1)(a) of SEBI LODR for Gujarat Kidney and Super Speciality Limited as on December 26, 2025.

Summary

Gujarat Kidney and Super Speciality Limited has filed its post-issue shareholding pattern under Regulation 31(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The pattern is dated December 26, 2025, reflecting the shareholding structure after the listing of equity shares.

Key Points

  • Entity: Gujarat Kidney and Super Speciality Limited
  • Security Type: Equity Shares
  • Filing Basis: Regulation 31(1)(a) - Post Issue
  • Reference Date: December 26, 2025
  • Company has issued partly paid-up shares (Yes)
  • Company has convertible securities outstanding (Yes)
  • No warrants, ESOPs, depository receipts, or differential voting rights shares issued
  • No promoter shareholding is pledged or under non-disposal undertaking
  • No locked-in shares reported
  • No significant beneficial owners identified

Regulatory Changes

No regulatory changes introduced. This is a standard disclosure requirement under existing SEBI LODR Regulations.

Compliance Requirements

  • Listed entities must file shareholding pattern under Regulation 31 of SEBI LODR
  • Post-issue shareholding pattern must be submitted following the listing of securities
  • Declaration of various shareholding characteristics (partly paid shares, convertible securities, encumbrances, etc.) is mandatory
  • Shareholding data must be provided in the prescribed tabular format showing promoter, public, and non-promoter holdings

Important Dates

  • December 26, 2025: Reference date for post-issue shareholding pattern
  • December 29, 2025: Circular publication date

Impact Assessment

This is a routine compliance disclosure with minimal market impact. The filing provides transparency regarding the company’s shareholding structure following its equity listing. The presence of partly paid-up shares and outstanding convertible securities indicates a recent capital raising activity. Investors and market participants can use this information to understand the ownership distribution and potential dilution from convertible securities.

Impact Justification

Routine post-issue shareholding pattern disclosure for a newly listed entity with no immediate market impact